Where we ship from Mumbai.
Forty-five-plus countries, ten regions, one operational discipline. Our market reach is built around the regulators we actually know, MHRA, ANSM, BfArM, SFDA, MOHAP, EDA, JFDA, ANVISA, COFEPRIS, INVIMA, ISP, DIGEMID, DAV, Thai FDA, NPRA, DGDA, NMRA, DDA, NAFDAC, PPB, TMDA, NDA, SAHPRA, EFDA, ANARME, ACOREP, AIRP, ARP, DPML, DMP, NCEMM, UzPharm, AGEMA, DLS, PFDA, not a list of pins on a map.
Regulated, predictable, paperwork-heavy.
Our London desk handles UK and European accounts, MHRA, ANSM and BfArM liaison, Specials and named-patient routes, French-language labelling for ANSM, and the procurement paperwork that defines NHS, AP-HP and UniHA supply.
GCC, our Dubai team's home turf.
Dedicated desks for SFDA, MOHAP, DHA, the Gulf Health Council, and the tender desks that run Gulf public-sector procurement. Bonded warehousing available for JAFZA and DAFZA operations.
MENA, beyond the GCC.
Egypt's EDA is the largest Africa pharma market; Jordan's JFDA sits adjacent to the GCC recognition net; Iraq runs two tracks, federal Kimadia and the Kurdistan Region MOH; Morocco's DMP and Tanger Med anchor Maghreb commerce; Tunisia's PCT runs an institutional import monopoly. French and Arabic dossier capability where the regulator demands it; tender-aware commercial schedules on every file.
West, East and Southern Africa.
From Lagos to Nairobi to Johannesburg to Addis Ababa, NAFDAC, PPB, TMDA, NDA, SAHPRA, EFDA and the NGO and central-medical-stores procurement bodies (NMS, JMS, MSD, EPSS) that supply much of the region's hospital formulary. WHO PQ lines, EAC-harmonised dossiers and named-supplier status on multiple national tenders.
The shortest international lanes we run.
Sri Lanka and Nepal are the two markets where India is structurally the dominant pharmaceutical source, where bilateral recognition between CDSCO and the destination regulator runs faster than any other corridor, and where INR or LKR settlement removes the FX-exposure friction that complicates every other Asian lane. Mumbai-Colombo is short-haul air, Mumbai-Birgunj is overland road; documentation written in CTD and English clears on first pass.
ASEAN, ACTD-aligned filings.
Our Singapore desk handles ASEAN-wide regulatory coordination and ACTD-harmonised dossier preparation. Vietnamese DAV filings, Thai FDA and GPO tenders, Malaysian NPRA + Pharmaniaga state-channel supply (with halal certification where the dosage form requires it), Philippine FDA filings, DOH and PhilHealth tender response, and Mercury Drug retail channel support from Manila to Cebu.
LATAM, Spanish-CTD documentation, public-private dual channels.
Three Andean and Caribbean-Pacific markets where Indian generic pharmaceuticals have material share against the Spanish-language regulatory cost. Peru runs CENARES tenders alongside EsSalud social-security procurement; Chile is the most reliable LATAM payment counterparty with CENABAST as the single state buyer; Colombia's INVIMA reform and 2024 oncology procurement reset opened space for biosimilar competition that aligns with M Care's oncology strength.
Russian-language CTD, single-buyer tenders, sanctions-clean USD.
Kazakhstan's SK-Pharmacy is one of the most concentrated public pharma procurement structures in the world; Uzbekistan since the 2017 Mirziyoyev reforms has restored hard-currency convertibility and become a top-three Indian-pharma destination growing 12 to 15 per cent year on year. Both lanes need Russian-language NCEMM or UzPharm dossiers; both are sanctions-clean for USD invoicing despite EAEU adjacency; both support INR settlement via SBI's bilateral arrangements.
AGEMA dossiers, TƏBIB tender supply, AZN-pegged stability.
Azerbaijan reformed its central pharmaceutical procurement in 2019 around TƏBIB LLC, which now consolidates state-hospital demand into a single tender desk. AGEMA-aligned Russian-language dossiers, BOM-GYD direct freight via Doha or Istanbul, and AZN's USD peg make the Caucasus lane operationally clean.
Donor-procurement and ProZorro tender supply.
Ukraine's pharmaceutical demand is being served through three parallel channels: international donor procurement run by UN agencies and Crown Agents, the open ProZorro e-tender platform for state Ministry of Health buying, and direct private-hospital procurement in non-front-line oblasts. Indian WHO-Prequalified product moves through validated overland-via-Poland routing on cold-chain lanes from Mumbai. Ukraine is sanctions-clean: Indian exporters face no compliance friction, only war-risk and logistics-risk.
Ad-hoc enquiries from outside the forty-five.
The forty-five countries above are the markets where we have dedicated desks and repeat-order tender relationships. We also take ad-hoc enquiries from outside that list on a case-by-case basis, named-patient imports, NGO procurements, one-off tender bids. Send us your brief and we'll confirm whether we can route it.
Ask about your market →